Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies: a Cross-over Randomized Clinical Trail

NCT05402397 is registered in ClinicalTrials.gov with Hospital General de Niños Pedro de Elizalde as lead sponsor.

NCT NCT05402397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05402397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies: a Cross-over Randomized Clinical Trail
Lead sponsor
Hospital General de Niños Pedro de Elizalde
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2022
Completion date
January 1, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uric acid nephropathy